[1]
S. Mongiorgi, “Differential activation of nuclear inositide-dependent signalling pathways during erythropoiesis and myelopoiesis induced by lenalidomide and azacitidine in myelodysplastic syndromes (MDS)”, Ital J Anat Embryol, vol. 120, no. 1, p. 108, Sep. 2015.